FDA halts RAPT Therapeutics trials due to liver failure case

Published on 20 Feb 2024 on Investing.com

The U.S. Food and Drug Administration (FDA) has verbally informed the company of a hold on its Phase...

Read the rest of the article

Start tracking your investments with Statfolio

We recently published a list of 15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers...

Insider Monkey · via Yahoo Finance 24 Sep 2024

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small...

Insider Monkey · via Yahoo Finance 20 Jun 2024

What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday? On Thursday, RAPT Th...

Benzinga via Yahoo Finance 9 May 2024

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small...

Insider Monkey via Yahoo Finance 22 Mar 2024

Investors are always looking for stocks that are poised to beat at earnings season and RAPT Thera...

Zacks via Yahoo Finance 7 Mar 2024

For Immediate Release Chicago, IL – February 23, 2024 – Zacks.com announces the list of stocks fe...

Zacks via Yahoo Finance 23 Feb 2024

The recent price decline of 73% in RAPT Therapeutics, Inc.'s (NASDAQ:RAPT) stock may have disappo...

Simply Wall St. via Yahoo Finance 21 Feb 2024

Tuesday, the FDA verbally notified RAPT Therapeutics Inc RAPT that a clinical hold has been place...

Benzinga 21 Feb 2024

The U.S. Food and Drug Administration (FDA) has verbally informed the company of a hold on its Ph...

Investing.com 20 Feb 2024

<img src=https://s.yimg.com/ny/api/res/1.2/OJolqZFB5GvM9xdrGNUkFg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2O...

GuruFocus.com via Yahoo Finance 15 Nov 2023